119 related articles for article (PubMed ID: 9717083)
1. Immunological abnormality associated with the augmented nitric oxide synthesis in adjuvant-induced arthritis.
Tanaka S; Matsui T; Murakami T; Ishizuka T; Sugiura M; Kawashima K; Sugita T
Int J Immunopharmacol; 1998; 20(1-3):71-84. PubMed ID: 9717083
[TBL] [Abstract][Full Text] [Related]
2. Modulation of nitric oxide synthesis in inflammation. Relationship to oxygen-derived free radicals and prostaglandin synthesis.
Gad MZ; Khattab M
Arzneimittelforschung; 2000 May; 50(5):449-55. PubMed ID: 10858872
[TBL] [Abstract][Full Text] [Related]
3. KE-298 and its active metabolite KE-758 suppress nitric oxide production by murine macrophage cells and peritoneal cells from rats with adjuvant induced arthritis.
Inoue T; Hamada Y; Takeshita K; Fukushima K; Higaki M
J Rheumatol; 2001 Jun; 28(6):1229-37. PubMed ID: 11409114
[TBL] [Abstract][Full Text] [Related]
4. Association between the expression of inducible nitric oxide synthase by chondrocytes and its nitric oxide-generating activity in adjuvant arthritis in rats.
Yonekura Y; Koshiishi I; Yamada K; Mori A; Uchida S; Nakamura T; Utsumi H
Nitric Oxide; 2003 May; 8(3):164-9. PubMed ID: 12826065
[TBL] [Abstract][Full Text] [Related]
5. Comparison of the nitric oxide synthase inhibitors methylarginine and aminoguanidine as prophylactic and therapeutic agents in rat adjuvant arthritis.
Stefanovic-Racic M; Meyers K; Meschter C; Coffey JW; Hoffman RA; Evans CH
J Rheumatol; 1995 Oct; 22(10):1922-8. PubMed ID: 8991992
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic administration of a selective inhibitor of nitric oxide synthase does not ameliorate the chronic inflammation and tissue damage associated with adjuvant-induced arthritis in rats.
Fletcher DS; Widmer WR; Luell S; Christen A; Orevillo C; Shah S; Visco D
J Pharmacol Exp Ther; 1998 Feb; 284(2):714-21. PubMed ID: 9454819
[TBL] [Abstract][Full Text] [Related]
7. The inhibition of inducible nitric oxide synthase reverts arthritic-induced decrease in pituitary growth hormone mRNA but not in liver insulin-like growth factor I mRNA expression.
Ibáñez de Cáceres I; Priego T; Martín AI; López-Calderón A; Villanúa MA
J Neuroendocrinol; 2003 Dec; 15(12):1178-84. PubMed ID: 14636180
[TBL] [Abstract][Full Text] [Related]
8. Selective inhibition of inducible nitric oxide synthase exacerbates erosive joint disease.
McCartney-Francis NL; Song X; Mizel DE; Wahl SM
J Immunol; 2001 Feb; 166(4):2734-40. PubMed ID: 11160339
[TBL] [Abstract][Full Text] [Related]
9. Nitric oxide: a key mediator in the early and late phase of carrageenan-induced rat paw inflammation.
Salvemini D; Wang ZQ; Wyatt PS; Bourdon DM; Marino MH; Manning PT; Currie MG
Br J Pharmacol; 1996 Jun; 118(4):829-38. PubMed ID: 8799551
[TBL] [Abstract][Full Text] [Related]
10. Dual effect of nitric oxide in articular inflammatory pain in zymosan-induced arthritis in rats.
da S Rocha JC; Peixoto ME; Jancar S; de Q Cunha F; de A Ribeiro R; da Rocha FA
Br J Pharmacol; 2002 Jun; 136(4):588-96. PubMed ID: 12055137
[TBL] [Abstract][Full Text] [Related]
11. Recipient humoral immunity against leukoreduced allogeneic platelets is suppressed by aminoguanidine, a selective inhibitor of inducible nitric oxide synthase.
Bang A; Speck ER; Blanchette VS; Freedman J; Semple JW
Blood; 1996 Oct; 88(8):2959-66. PubMed ID: 8874192
[TBL] [Abstract][Full Text] [Related]
12. Role of endothelial nitric oxide synthase in aggravation of indomethacin-induced gastric damage in adjuvant arthritic rats.
Kato S; Ohkawa F; Ito Y; Amagase K; Takeuchi K
J Physiol Pharmacol; 2009 Dec; 60(4):147-55. PubMed ID: 20065509
[TBL] [Abstract][Full Text] [Related]
13. Chronic administration of aminoguanidine reduces vascular nitric oxide production and attenuates liver damage in bile duct-ligated rats.
Wei CL; Hon WM; Lee KH; Khoo HE
Liver Int; 2005 Jun; 25(3):647-56. PubMed ID: 15910502
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic administration of 3,4,5-trimethoxy-4'-fluorochalcone, a selective inhibitor of iNOS expression, attenuates the development of adjuvant-induced arthritis in rats.
Rojas J; Payá M; Devesa I; Dominguez JN; Ferrándiz ML
Naunyn Schmiedebergs Arch Pharmacol; 2003 Sep; 368(3):225-33. PubMed ID: 12904830
[TBL] [Abstract][Full Text] [Related]
15. Effect of inducible nitric oxide synthase inhibition by aminoguanidine on insulin-like growth factor binding protein-3 in adjuvant-induced arthritic rats.
Ibáñez de Cáceres I; Priego T; Martín AI; Granado M; López-Calderón A; Villanúa MA
Eur J Pharmacol; 2003 Nov; 481(2-3):293-9. PubMed ID: 14642797
[TBL] [Abstract][Full Text] [Related]
16. Rutin and rutin-conjugated gold nanoparticles ameliorate collagen-induced arthritis in rats through inhibition of NF-κB and iNOS activation.
Gul A; Kunwar B; Mazhar M; Faizi S; Ahmed D; Shah MR; Simjee SU
Int Immunopharmacol; 2018 Jun; 59():310-317. PubMed ID: 29679855
[TBL] [Abstract][Full Text] [Related]
17. Modulation of adjuvant arthritis by endogenous nitric oxide.
Ialenti A; Moncada S; Di Rosa M
Br J Pharmacol; 1993 Oct; 110(2):701-6. PubMed ID: 8242242
[TBL] [Abstract][Full Text] [Related]
18. Evidence that inducible nitric oxide synthase is involved in LPS-induced plasma leakage in rat skin through the activation of nuclear factor-kappaB.
Iuvone T; D'Acquisto F; Van Osselaer N; Di Rosa M; Carnuccio R; Herman AG
Br J Pharmacol; 1998 Apr; 123(7):1325-30. PubMed ID: 9579726
[TBL] [Abstract][Full Text] [Related]
19. Suppression of adjuvant-induced arthritis by selective inhibition of inducible nitric oxide synthase.
Connor JR; Manning PT; Settle SL; Moore WM; Jerome GM; Webber RK; Tjoeng FS; Currie MG
Eur J Pharmacol; 1995 Jan; 273(1-2):15-24. PubMed ID: 7537678
[TBL] [Abstract][Full Text] [Related]
20. Inducible nitric oxide synthase in vascular smooth muscle cells from prehypertensive spontaneously hypertensive rats.
Singh A; Sventek P; Larivière R; Thibault G; Schiffrin EL
Am J Hypertens; 1996 Sep; 9(9):867-77. PubMed ID: 8879343
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
